Press release
Track Nicotinamide Price Index Historical and Forecast
Nicotinamide Price Trend and Forecast Report - Global Market Insights, Regional Dynamics, and Procurement OutlookExecutive Summary
The global Nicotinamide (Vitamin B3) market showcased significant volatility from 2024 through Q3 2025, driven by shifting downstream demand patterns, stabilizing supply chains, evolving production cost structures, and fluctuating inventory positions across major regions. The market moved from the heightened price cycles of 2024 into a more deflationary environment through 2025, reflecting large supply availability, cautious procurement sentiment, and subdued nutraceutical, pharmaceutical, and personal care consumption.
Across North America, APAC, and Europe, Nicotinamide prices declined notably, with Q3 2025 registering quarter-over-quarter drops of 9.14%, 8.68%, and 8.31%, respectively. Elevated inventories, efficient logistics, and aggressive export offers from major Asian suppliers continued to suppress spot prices. Meanwhile, cost trends stabilized as maize- and glucose-derived feedstocks registered notable price declines globally, easing production pressures for manufacturers.
Despite bearish market conditions through mid-2025, selective restocking activity, normalizing inventories, and firmer export quotations in some markets contributed to emerging stabilization signals. As industries prepare for Q4 2025 and early 2026 procurement cycles, suppliers and buyers alike are shifting strategies toward cautious rebuilding, mitigating price risks, and anticipating incremental recovery in downstream demand.
◼ Get Instant Access to Live Nicotinamide Prices Today: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Nicotinamide
Introduction
Nicotinamide, also known as niacinamide or Vitamin B3, remains an essential raw material across pharmaceuticals, nutraceuticals, fortified food formulations, cosmetics, skincare, and animal nutrition. Its importance within core health and wellness supply chains makes price transparency crucial for global procurement teams.
Over the past 12-15 months, the Nicotinamide market has undergone significant transformation. The year 2024 witnessed volatility due to shifting export policies, post-pandemic demand normalization, and uneven recovery cycles across consumer segments. Entering 2025, the market transitioned into a phase marked by broad oversupply, weakening consumption patterns, and deflationary pressure across all key regions.
Buyers across the value chain-including manufacturers, formulators, distributors, and global importers-have adopted increasingly cautious strategies amid soft demand conditions, abundant stocks, and steady production flows from leading Asia-Pacific origins such as China and India.
This report consolidates granular quarterly insights, evaluates the drivers behind regional price movements, examines production and cost structures, and outlines the procurement and market outlook for the upcoming months.
Global Nicotinamide Price Overview
The global Nicotinamide market in 2025 has been characterized by:
Weak downstream demand, especially in pharmaceuticals, nutrition, personal care, and functional foods.
High inventory carryovers, particularly after the end of 2024 and Q1 2025.
Aggressive export offerings, as Chinese and Indian manufacturers operated at uninterrupted capacity.
Lower production costs, supported by declining feedstock maize and glucose prices.
Smooth logistics, with no major freight disruptions across major global ports.
Cautious procurement, with buyers relying heavily on internal stock before engaging in new contracts.
By the end of Q3 2025, global prices reflected consistent downward pressure, although early signs of stabilization appeared in some markets where restocking resumed selectively.
◼ Monitor Real-Time Nicotinamide Price Swings and Stay Ahead of Competitors: https://www.chemanalyst.com/Pricing-data/nicotinamide-1638
Regional Market Analysis
North America Market Overview (USA)
Q3 2025 Market Performance
In the United States, the Nicotinamide Price Index declined 9.14% quarter-over-quarter during Q3 2025. The average price stood at USD 4736.67/MT, reflecting subdued downstream demand.
Key drivers included:
Elevated importer inventories, eliminating urgent restocking needs.
Weak nutraceutical and personal care offtake, suppressing spot demand.
Steady supply flows and abundant export availability, limiting upward price movements.
Uninterrupted logistics, meaning price fluctuations were tied purely to demand-side weakness.
Selective procurement activity, with buyers purchasing only essential volumes.
Despite weak fundamentals, the Nicotinamide Price Forecast suggested mild recovery potential driven by restocking ahead of Q4 and stable production costs.
Why Did the Price Change in September 2025 in North America?
Importers carried excess inventories, putting sustained downward pressure on the Price Index.
Downstream nutraceutical and personal care sectors maintained low purchasing levels.
Exporters softened offer prices, given ample production and competitive pressures.
Stable logistics conditions removed any structural price support.
Q2 2025 Market Dynamics
By June 2025, the CFR Los Angeles Spot Price reached USD 5010/MT, with a 1.57% MoM drop in June following an 8.12% plunge in May.
Reasons for ongoing price softness:
Persistently low procurement from pharmaceuticals and food-grade formulations.
High inventory carryovers, which significantly delayed Q3 restocking.
Consistent exports from major Asian producers, with no supply bottlenecks.
Global cost reductions, driven by falling maize prices.
Anticipatory buying delays, as buyers expected further price corrections.
Aggressive pricing from Chinese and Indian exporters seeking to clear slow-moving stock.
Why Did the Price Change in July 2025 in North America?
The decline continued due to:
Unimproved consumption in downstream sectors.
High inventories discouraging new purchase cycles.
Lack of policy or freight disruptions.
Ongoing bearish sentiment in global markets.
Q1 2025 Performance
In Q1 2025:
Nicotinamide prices in North America fell 16.64%.
Weak demand persisted across pharmaceuticals, supplements, and personal care.
Inventories carried over from late 2024 reduced fresh procurement.
Seasonal transitions lowered Vitamin B3 consumption.
Logistics remained stable, enabling consistent supply flow.
Pricing strategies remained competitive due to tariff-related margin pressures.
Q4 2024 Insights
North America saw:
Firmness in October 2024, driven by supply concerns.
Persistent weakness through December, as inventories rose.
Destocking initiatives, especially as year-end approached.
A downturn in animal feed demand.
Strategic buyer caution and wait-and-watch procurement behavior.
◼ Track Daily Nicotinamide Price Updates and Strengthen Your Procurement Decisions: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Nicotinamide
APAC Market Overview (South Korea Focus)
Q3 2025 Market Performance
In South Korea, prices fell 8.68% quarter-over-quarter, with an average price of USD 4666.67/MT.
Key drivers include:
Persistently weak demand, especially early in the quarter.
Steady export volumes, limiting upward spot momentum.
Lower feedstock and energy costs, reducing production pressure.
A shift in buyer strategy from opportunistic to coverage-oriented.
Smooth regional logistics supporting stable availability.
Why Did the Price Change in September 2025 in APAC?
Buyer coverage renewed, tightening short-term spot demand.
Export offers firmed as suppliers reduced discounts.
Inventories began normalizing but remained high.
Restocking supported moderate recovery without causing price spikes.
Q2 2025 Market Dynamics
By June 2025, the CFR Busan price stood at USD 4850/MT, down 3.19% from May, capping an extended decline.
Key factors:
Weak restocking from pharmaceuticals and functional food producers.
Downstream caution following Chinese Lunar New Year disruptions.
Elevated inventories limiting forward buying.
Full production capacity across China and India creating oversupply.
Falling maize/glucose prices lowering production costs.
Smooth logistics providing consistent availability.
Aggressive export price reductions from major suppliers.
Why Did the Price Change in July 2025 in APAC?
Weak downstream engagement.
Heavy inventory positions.
Zero logistical disruptions.
Highly competitive exporter pricing.
Absence of demand revival catalysts.
Q1 2025 Performance
APAC saw a 16.32% QoQ price decline during Q1 2025.
Key contributors:
Lunar New Year slowdown.
High carryover stocks limiting new purchases.
Soft nutraceutical and personal care demand.
Routine pharmaceutical consumption patterns.
Smooth regional supply chains with efficient port operations.
Q4 2024 Insights
In APAC, Q4 2024 experienced:
Initial price firmness in October driven by production cost increases.
Rapid demand softening after Golden Week.
Rising competition among manufacturers.
Elevated inventories and slow-moving stock prompting aggressive destocking.
Stable logistics and intense export competition.
◼ Unlock Live Pricing Dashboards for Accurate and Timely Insights: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Nicotinamide
Europe Market Overview (Germany Focus)
Q3 2025 Market Performance
Germany witnessed an 8.31% quarter-over-quarter price decline, with an average price of USD 4743.33/MT.
Drivers included:
Weak downstream nutraceutical and pharmaceutical demand.
Ample exports suppressing spot prices.
Stable production and logistics.
Slow but emerging restocking ahead of Q4.
Why Did the Price Change in September 2025 in Europe?
Synchronized restocking after July lows increased demand.
Export offers firmed, lifting CFR landed costs.
Downstream recovery reduced inventories.
Tightening availability pushed prices moderately higher.
Q2 2025 Market Dynamics
The CFR Hamburg price in June 2025 was USD 4930/MT, down 2.57% MoM, following an 8.5% fall in May.
Buyers deferred purchases due to high inventories.
Weak downstream uptake from supplements and skincare.
Stable port operations and abundant supply.
Asian exporters reduced quotations aggressively.
Production costs remained subdued globally.
Buyers focused entirely on real-time consumption, avoiding speculative purchases.
Q1 2025 Performance
Europe recorded a 17.29% average price drop in Q1 2025 due to:
High Q4 2024 inventory levels.
Soft post-winter personal care and supplement consumption.
Stable regional logistics.
Routine production cycles preventing shortages.
Q4 2024 Insights
Europe experienced:
Firm price sentiment in October, followed by sustained declines.
Strong competition among distributors.
Significant destocking pressure in December.
Seasonal slowdown in downstream consumption.
Production and Cost Structure Insights
Global Nicotinamide production costs remained stable to weaker throughout 2025 due to:
Declining maize and glucose feedstock prices.
Improved energy availability.
Stable labor and operations conditions in China and India.
Economies of scale in large integrated facilities.
Lower production costs enabled:
More competitive export pricing.
Ability to maintain margins even with softened global demand.
Continuous production cycles despite slow-moving inventories.
Procurement Behavior & Market Outlook
Key Procurement Trends Observed:
Buyers delayed major purchases through Q2-Q3 2025.
Procurement was strictly need-based, with many distributors exhausting internal inventory first.
Forward contracting reduced significantly due to ongoing price declines.
Buyers showed stronger engagement only during selective restocking phases in Q3.
Outlook for Q4 2025 and Early 2026
Gradual inventory normalization may lift spot prices modestly.
Downstream demand from nutraceuticals, fortified foods, and personal care is expected to improve seasonally.
Export offers may firm slightly if feedstock costs rebound.
Markets will remain sensitive to macroeconomic indicators, freight rate changes, and consumer demand recovery.
◼ Stay Updated Each Day with Verified Nicotinamide Price Movements: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Nicotinamide
Frequently Asked Questions (FAQ)
Why did Nicotinamide prices fall across global markets in mid-2025?
Due to oversupply, elevated inventories, slow downstream demand, competitive export offers, and stable production and logistics.
What is the main factor behind weak pharmaceutical demand?
Routine Vitamin B3 formulation cycles and normalized consumption patterns post-winter and post-pandemic.
How did falling maize prices affect Nicotinamide costs?
Lower maize and glucose prices reduced fermentation-based production costs, enabling cheaper export offers.
Why did APAC prices show slight recovery signals in September 2025?
Renewed buyer coverage, firmer export offers, and gradually normalizing inventories.
Is a price rebound expected in Q4 2025?
A mild recovery is possible with restocking cycles and improved downstream consumption.
Why did Europe face sharp declines in Q2 2025?
High stocks, weak supplement demand, and reduced export quotations from Asia.
What role did logistics play in 2025 price trends?
Efficient global logistics removed supply-side price support, making demand the primary driver.
How ChemAnalyst Supports Buyers with Real-Time Data, Forecasts & Market Intelligence
ChemAnalyst empowers procurement teams, manufacturers, and supply-chain stakeholders with the most accurate, real-time, and forward-looking insights in the Nicotinamide market and across 450+ other chemicals and commodities.
ChemAnalyst offers:
Real-Time Price Tracking - live updates across global markets.
Weekly Price Reports - covering trends, drivers, and forecast interpretations.
Expert-led Market Analysis - by chemical engineers and economists.
Accurate Price Forecasts - to optimize purchase timing and budgeting.
Plant Shutdown & Capacity Monitoring - evaluating supply-risk scenarios.
Demand & Supply Modelling - enabling strategic procurement planning.
Ground Intelligence - from 50+ major trade ports including Houston, Busan, Rotterdam, Shanghai, Jebel Ali, Hamburg, and Antwerp.
Contact Us:
UNITED STATES
Call +1 3322586602
420 Lexington Avenue, Suite 300, New York, NY,
United States, 10170
Germany
Call +49-221-6505-8833
S-01, 2.floor, Subbelrather Straße,
15a Cologne, 50823, Germany
Website: https://www.chemanalyst.com/
About Us:
Welcome to ChemAnalyst, a next-generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as "Product Innovator of the Year 2023" and ranked among the "Top 100 Digital Procurement Solutions Companies," we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Track Nicotinamide Price Index Historical and Forecast here
News-ID: 4281466 • Views: …
More Releases from ChemAnalyst
Track Naproxen Price Report Historical and Forecast
Naproxen Price Trend and Forecast: Q4 2024 - Q3 2025
Executive Summary
The global Naproxen market has experienced dynamic pricing trends over the past year, influenced by a combination of seasonal demand cycles, raw material availability, export behaviors, and logistical efficiencies. For the quarter ending September 2025, Naproxen prices showed modest upward pressure in North America, APAC, and Europe, reflecting measured restocking ahead of seasonal demand and steady pharmaceutical procurement.
In North America,…
Track Monosulfiram Price Trend Historical and Forecast
Monosulfiram Price Trend and Forecast: Q3 2025 Analysis and Regional Outlook
Executive Summary
The Monosulfiram market experienced moderate but regionally varied price movements during Q3 2025, reflecting nuanced dynamics across global supply chains, seasonal demand patterns, and procurement behaviors. In North America, prices showed modest upward momentum, underpinned by low distributor inventories and steady end-use consumption in veterinary, personal care, and topical pharmaceutical sectors. Conversely, in APAC, the price index softened slightly,…
Track Monosodium Glutamate (MSG) Price Index Historical and Forecast
Monosodium Glutamate (MSG) Price Trend and Forecast
Executive Summary
The global Monosodium Glutamate (MSG) market has exhibited nuanced price movements in 2024-2025, shaped by a balance of supply dynamics, input cost fluctuations, and varying regional demand patterns. As of the quarter ending September 2025, North America, APAC, and Europe have all experienced slight softening in the MSG Price Index, driven by factors such as carryover surplus, modest procurement, and stable logistics. While…
Track Monocalcium Phosphate Price Trend Historical and Forecast
Monocalcium Phosphate Price Trend and Forecast: Global Market Dynamics, Regional Analysis, and Procurement Outlook
Executive Summary
The global Monocalcium Phosphate (MCP) market has navigated significant price volatility over the past year, shaped by evolving demand conditions, fluctuating feedstock trends, macroeconomic pressures, and supply-chain realignments across North America, the Asia-Pacific (APAC), and Europe. From the sharp swings of Q4 2024 to the stabilizing yet regionally varied performance through 2025, the market has reflected…
More Releases for Nicotinamide
Nicotinamide D4 Market Revenue, Insights, Overview, Outlook, Analysis
Nicotinamide D4 Market
Nicotinamide-d4 is an analogue of nicotinamide, which is a vitamin found in food. It can be used to measure the amount of estrogens present in water and wastewater. Nicotinamide-d4 has been shown to have a stabilization effect on proteins.
The global Nicotinamide D4 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast…
Nicotinamide Mononucleotide (NMN) Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Nicotinamide Mononucleotide (NMN) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
Nicotinamide Mononucleotide Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Nicotinamide Mononucleotide Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Nicotinamide Mononucleotide players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nicotinamide Mononucleotide with respect to individual growth…
Nicotinamide Essence Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Nicotinamide Essence Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Nicotinamide Essence market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
Nicotinamide Market with Regional Assessment of 2025
The world is facing tremendous increase in the incidence of diabetes mellitus, cardiac problems, and vitamin deficiency. For combating these challenges, cost-effective and complementary therapies are required. Diabetes has now been classified as a vascular disease and the cost of treating and controlling the micro-vascular component is a serious problem, specifically in developing countries. Niacinamide or nicotinamide is an essential vitamin and also an essential constituent of co-enzymes found in…
Nicotinamide Market Global Market Opportunity Assessment Study 2025.
The world is facing tremendous increase in the incidence of diabetes mellitus, cardiac problems, and vitamin deficiency. For combating these challenges, cost-effective and complementary therapies are required. Diabetes has now been classified as a vascular disease and the cost of treating and controlling the micro-vascular component is a serious problem, specifically in developing countries. Niacinamide or nicotinamide is an essential vitamin and also an essential constituent of co-enzymes found in…
